BioSpace News Archive

Forward BIOLABS, a co-working life science lab that helps bioscience startups grow, is celebrating early successes and honoring the companies that support the organization.

DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced the appointment of Herb Cross, a seasoned financial and operational executive, to its board of directors.

FX received their 510k clearance for the Easytech® Stemless Anatomic. It is the only stemless shoulder prosthesis on the market with primary peripheral fixation.

Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced the appointment of LeAnne M. Zumwalt to its Board of Directors, effective February 16, 2021 .

LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing.

GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage biopharmaceutical company focused on the development and commercialization of its disruptive, target-directed Natural Killer (NK) cell engager immunotherapy protein biologic platform technology: TriKE™ for cancer and infectious diseases, today announced it has signed an expanded GMP manufacturing agreement with Cytovance

RhythMedix, a leader in remote cardiac monitoring, today announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity.

Anticipated PDUFA for PRX-102 in Fabry disease currently set for April 27, 2021 Company, with its Commercialization Partner, Chiesi, poised to commercialize PRX-102 Additional data and milestones expected throughout 2021

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report fourth quarter and full year 2020 financial results on Thursday, February 25, 2021

The Company hosted President Reuven Rivlin and Mayor of Beer Sheva, Mr. Ruvik Danilovich, to discuss the Allscripts dbMotion™ Solution’s role in connecting all clinical venues across Israel